Economic Impact of Diabetes in Japan
- 34 Downloads
Purpose of review
The economic burden of diabetes in Japan is already serious and will become greater in the future. We review the economic impact of diabetes in Japan to examine viable options for mitigating its effects.
Medical costs for diabetes have been increasing by US $1 million annually, reaching US $11 million in 2009, of which US $7 million was accounted for by people aged 65 years or older. The quality of treatment of diabetes in Japan is higher than in other regions in the world. This can be more effective for achieving glycemic control, but is also more expensive compared with conventional treatment.
Because of the high cost of diabetes in Japan, a coordinated response is needed. Intervention trials for people with prediabetes aimed at preventing the occurrence of diabetes seem to be the most cost-effective method for lowering the medical costs of diabetes, rather than the use of new, expensive antidiabetic drugs in patients with established diabetes.
KeywordsDiabetes Economic impact Intervention trial Japan Medical cost
Compliance with Ethical Standards
Conflict of Interest
Tatsuhiko Urakami, Remi Kuwabara, and Kei Yoshida declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 1.International Diabetes Federation, editor. Diabetes Atlas. 6th ed: International Diabetes Federation; 2013.Google Scholar
- 2.• Health and Welfare Statistics Association. Kokumin Eisei no Doko (Trends in Nation’s Health, Japan). Health and Welfare Statistics Association: Tokyo; 2015 (in Japanese). This study provides annual national health trends in Japan.Google Scholar
- 4.Sagel JE. Cost-off-illness studies-A primer, RTI-UNC Center of Excellence in Health Promotion Economics; 2006.Google Scholar
- 7.Vos T, Gross J, Begg S, Mann N. Projection of health care expenditure by disease: a case study from Australia. Brisbane, Australia: School of population Health, University of Queensland; 2007.Google Scholar
- 12.• Seuring T, Archangelidi O, Suhrcke. The economic costs of type 2 diabetes: A global systemic review. Pharmacoeconomics. 2015;33:811–31 This study reviews the societal cost of type 2 diabetes worldwide, estimated using direct and indirect costs based on previously published literature.CrossRefGoogle Scholar
- 13.•• Bommer C, Sagalova V, Heesemann E, Manne-Goehler J, Atun R, Bärnighausen T, et al. Global economic burden of diabetes in adults: projections from 2015 to 2030. Diabetes Care. 2018;41:963–70 This study reports the GDP-relative economic burden in individuals aged 20–79 years using epidemiological and demographic data in 184 countries, projected from 2015 for 2030.CrossRefGoogle Scholar
- 14.Health and Welfare Statistics Association. Kokumin Eisei no Doko (Trends in Nation’s Health, Japan). Tokyo: Health and Welfare Statistics Association; 2001. (in Japanese)Google Scholar
- 18.Inada O. Medical costs in type 2 diabetes. Himan to Tounyobyo. 2009;8:672–5 (in Japanese).Google Scholar
- 19.DCCT Research Group. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group. J Pediatr. 1994;125:177–88.CrossRefGoogle Scholar
- 21.Maruyama T. Medical costs in type 1 diabetes. Himan to Tounyobyo. 2009;8:670–1 (in Japanese).Google Scholar
- 22.• Kikuchi N, Tajima N, Ueki K, Yokoyama T, Ikegami H, Urakami T. Definition of complete insulin -dependent type 1 diabetes. Report of research grant from Ministry of Health, Labor and Welfare (H28-Junkanki-Ippan-006), 2018 (in Japanese). This report discusses the current economic status of diabetes treatment and management in 2018.Google Scholar
- 23.Aono S, Matsuura N, Ameiya S, Igrashi Y, Uchigata Y, Urakami T, et al. Epidemiological survey of social adjustment and living condition in patients with childhood onset insulin-dependent diabetes mellitus aged over 18 years. Tounyobyo. 1997;40:547–55 (in Japanese).Google Scholar
- 26.Hisashige A. Prevention of diabetes and economic efficacy. Prog Med. 2005;25:80–5 (in Japanese).Google Scholar